Transaction #5721 · Form 4 · 0001437749-25-033684
Moleculin Biotech, Inc. · Exercise / conversion · Common Stock
Moleculin Biotech, Inc. · Transacted November 4, 2025 · Filed November 6, 2025
What does this filing report?
An SEC Form 4 filing for Moleculin Biotech, Inc. records an exercise / conversion involving Common Stock on November 4, 2025. The reported quantity was 8,750. The filing date is November 6, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Moleculin Biotech, Inc.
- Company CIK
- 0001659617
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 8,750
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 18,902
- Ownership description
- Not reported
- SEC acceptance time
- Nov 6, 2025, 8:25 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- PICKER DONALD H ↗
Chief Science Officer
CIK 0001266800
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Restricted stock units convert into common stock on a one-for-one basis.
- F2
- Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- F3
- On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.